Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ubiquinol-cytochrome c reductase complex assembly factor 6 (UQCC6, also known as BRAWNIN) is a highly conserved, nuclear-encoded mitochondrial microprotein required for the assembly and stability of the mitochondrial respiratory chain complex III (cytochrome b-c1 complex), essential for electron transport and oxidative phosphorylation. UQCC6/BRAWNIN is localized to the inner mitochondrial membrane, where it functions as an early assembly factor of complex III, regulating mitochondrial ATP production in response to cellular energy status. Depletion or mutation of UQCC6 results in impaired complex III formation, reduced ATP production, metabolic dysfunction (including lactic acidosis), growth retardation, and early lethality in model organisms. UQCC6 expression is tightly regulated by the energy-sensing AMPK-PGC1α pathway, linking it to bioenergetic adaptation and potentially broader metabolic and immune functions[1][2][3][8].
Not applicable (no current drugs); future targeting would likely involve modulation of complex III assembly or mitochondrial function
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ubiquinol-cytochrome c reductase complex assembly factor 6 (UQCC6).